watch
Geron Corp.

Geron Corp.

Sector: In Vitro And In Vivo Diagnostic Substances Region: CA, United States


: | Nasdaq: GERN


Similar to: bioMérieux SA, Bio-Techne, Vitrolife AB

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of telomerase. Based on clinical data, they may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, which includes patients with primary MF, post-essential thrombocythemia MF, myelodysplastic syndromes, acute myelogenous leukemia. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

News & Analysis

You may also be interested in: